Search research articles
Contact Us
Filters
Showing results (721-730 of 743) with videos related to
Page
of 75
Sort By:
ACS Medicinal Chemistry Letters
|
June 6, 2014
Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists
Jian Jin, Angel Morales-Ramos, Patrick Eidam, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 27, 2008
Development of potent and selective small-molecule human Urotensin-II antagonists
John J McAtee, Jason W Dodson, Sarah E Dowdell, et al.
JACC. Cardiooncology
|
July 3, 2023
Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart Tissues
Annet N Linders, Itamar B Dias, Ekaterina S Ovchinnikova, et al.
Science Translational Medicine
|
August 30, 2023
A blood-based marker of mitochondrial DNA damage in Parkinson's disease
Rui Qi, Esther Sammler, Claudia P Gonzalez-Hunt, et al.
European Journal of Heart Failure
|
December 21, 2010
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
Thomas Eschenhagen, Thomas Force, Michael S Ewer, et al.
Blood
|
September 13, 2019
JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms
Tata Nageswara Rao, Nils Hansen, Julian Hilfiker, et al.
Nature
|
February 28, 2014
A large source of low-volatility secondary organic aerosol
Mikael Ehn, Joel A Thornton, Einhard Kleist, et al.
European Journal of Heart Failure
|
February 20, 2021
Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy
Karen Sliwa, Peter van der Meer, Mark C Petrie, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2008
Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles
John J McAtee, Jason W Dodson, Sarah E Dowdell, et al.
Circulation
|
April 20, 2021
Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy
Rahul Goli, Jian Li, Jeff Brandimarto, et al.
Page
of 75
Search research articles
Search
Showing results (721-730 of 743) with videos related to
Sort By:
Page
of 75
ACS Medicinal Chemistry Letters
|
June 6, 2014
Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists
Jian Jin, Angel Morales-Ramos, Patrick Eidam, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 27, 2008
Development of potent and selective small-molecule human Urotensin-II antagonists
John J McAtee, Jason W Dodson, Sarah E Dowdell, et al.
JACC. Cardiooncology
|
July 3, 2023
Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart Tissues
Annet N Linders, Itamar B Dias, Ekaterina S Ovchinnikova, et al.
Science Translational Medicine
|
August 30, 2023
A blood-based marker of mitochondrial DNA damage in Parkinson's disease
Rui Qi, Esther Sammler, Claudia P Gonzalez-Hunt, et al.
European Journal of Heart Failure
|
December 21, 2010
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
Thomas Eschenhagen, Thomas Force, Michael S Ewer, et al.
Blood
|
September 13, 2019
JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms
Tata Nageswara Rao, Nils Hansen, Julian Hilfiker, et al.
Nature
|
February 28, 2014
A large source of low-volatility secondary organic aerosol
Mikael Ehn, Joel A Thornton, Einhard Kleist, et al.
European Journal of Heart Failure
|
February 20, 2021
Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy
Karen Sliwa, Peter van der Meer, Mark C Petrie, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2008
Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles
John J McAtee, Jason W Dodson, Sarah E Dowdell, et al.
Circulation
|
April 20, 2021
Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy
Rahul Goli, Jian Li, Jeff Brandimarto, et al.
Page
of 75